Holen Sie sich die Stockscreener-App
11.37
0.00%
0.00
Schlusskurs vom Vortag:
$11.37
Offen:
$11.34
24-Stunden-Volumen:
979
Relative Volume:
0.07
Marktkapitalisierung:
$122.27M
Einnahmen:
-
Nettoeinkommen (Verlust:
$1.45M
KGV:
-15.81
EPS:
-0.7191
Netto-Cashflow:
$-705.90K
1W Leistung:
-0.09%
1M Leistung:
+0.53%
6M Leistung:
+3.55%
1J Leistung:
+7.46%
1-Tages-Spanne:
$11.34
$11.37
1-Wochen-Bereich:
$11.33
$11.42
52-Wochen-Spanne:
$10.59
$11.42
Keen Vision Acquisition Corp Stock (KVAC) Company Profile
Firmenname
Keen Vision Acquisition Corp
Sektor
Branche
Telefon
(203) 609-1394
Adresse
37 GREENBRIAR DRIVE, SUMMIT
Vergleichen Sie KVAC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
KVAC
Keen Vision Acquisition Corp
|
11.37 | 122.27M | 0 | 1.45M | -705.90K | -0.7191 |
|
LION
Lionsgate Studios Corp
|
5.81 | 1.91B | 2.82B | -191.60M | -407.10M | -0.6794 |
|
AACT
Ares Acquisition Corporation Ii
|
11.33 | 702.73M | 0 | 16.92M | -1.35M | 0.29 |
|
CCCM
Columbus Circle Capital Corp I
|
10.61 | 480.62M | 0 | 0 | 0 | 0.00 |
|
EQV
Eqv Ventures Acquisition Corp
|
10.55 | 468.90M | 0 | 0 | 0 | 0.00 |
|
ANSC
Agriculture Natural Solutions Acquisition Corp
|
10.83 | 465.53M | 0 | 1.30M | 0 | 0.0301 |
Keen Vision Acquisition Corp Aktie (KVAC) Neueste Nachrichten
Keen Vision Acquisition Co. (NASDAQ:KVAC) Sees Large Growth in Short Interest - MarketBeat
Medera and Novoheart Presented Breakthroughs in Human mini-Heart Platforms and Gene Therapy at ISSCR 2025 - GlobeNewswire
Toronto Dominion Bank Invests $304,000 in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Keen Vision Acquisition Co. (NASDAQ:KVAC) Short Interest Down 50.0% in May - MarketBeat
Polar Asset Management Partners Inc. Has $1.65 Million Holdings in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Toronto Dominion Bank Takes $304,000 Position in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Polar Asset Management Partners Inc. Sells 228,773 Shares of Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
KVACWKeen Vision Acquisition Corp Latest Stock News & Market Updates - Stock Titan
Medera Showcased Positive Interim Data From First-in-Human - GlobeNewswire
Keen Vision Acquisition Corp. SEC 10-Q Report - TradingView
Medera to Present Late-Breaking Phase 1/2a Clinical Trial Results at Heart Failure 2025 Congress - GlobeNewswire
Boothbay Fund Management LLC Sells 52,370 Shares of Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Keen Vision Acquisition Co. (NASDAQ:KVAC) Short Interest Up 33.3% in April - MarketBeat
AQR Arbitrage LLC Sells 230,549 Shares of Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Berkley W R Corp Trims Holdings in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
Quarry LP Lowers Stake in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
KVAC stock soars to all-time high, reaching $11.28 By Investing.com - Investing.com India
Keen Vision Acquisition extends merger deadline By Investing.com - Investing.com Canada
Spartan Fund Management Inc. Makes New Investment in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
KVAC stock soars to all-time high, reaching $11.28 - Investing.com
Keen Vision Acquisition extends merger deadline - Investing.com Australia
Medera to Go Public through Merger with KVAC - CHEManager
Keen Vision Acquisition Co. (NASDAQ:KVAC) Short Interest Down 62.5% in March - MarketBeat
$TOCKHOLDER ALERT: The M&A Class Action Firm Encourages Shareholders of PLYA, LTRPA, MHLD, KVAC to Act Now - Morningstar
Yakira Capital Management Inc. Buys New Position in Keen Vision Acquisition Co. (NASDAQ:KVAC) - MarketBeat
KVAC stock soars to all-time high of $11.26 amid market optimism - Investing.com Canada
KVAC stock soars to all-time high of $11.26 amid market optimism By Investing.com - Investing.com South Africa
Press Release Distribution & PR Platform - ACCESS Newswire
Medera Presented Updated Results from First-In-Human Gene - GlobeNewswire
Medera Presented Updated Results from First-In-Human Gene Therapy Trial for Heart Failure with Preserved Ejection Fraction at 2025 HFpEF Summit - Yahoo Finance
Finanzdaten der Keen Vision Acquisition Corp-Aktie (KVAC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.20%
0.14%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):